Europe Microfluidics Market Size & Outlook, 2026-2033

The microfluidics market in Europe is expected to reach a projected revenue of US$ 26,374.8 million by 2033. A compound annual growth rate of 10.4% is expected of Europe microfluidics market from 2026 to 2033.
Revenue, 2025 (US$M)
$11,846.0
Forecast, 2033 (US$M)
$26,374.8
CAGR, 2026 - 2033
10.4%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe microfluidics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe microfluidics market highlights

  • The Europe microfluidics market generated a revenue of USD 11,846.0 million in 2025.
  • The market is expected to grow at a CAGR of 10.4% from 2026 to 2033.
  • In terms of segment, microfluidic components was the largest revenue generating product in 2025.
  • Microfluidic Components is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 11,846.0 million
Market revenue in 2033USD 26,374.8 million
Growth rate10.4% (CAGR from 2026 to 2033)
Largest segmentMicrofluidic components
Fastest growing segmentMicrofluidic Components
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationMicrofluidic Components, Microfluidic-based Devices
Key market players worldwideIllumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 28.3% of the global microfluidics market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • MEA is the fastest growing regional market and is projected to reach USD 7,674.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Microfluidics Market Companies

Name Profile # Employees HQ Website
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Standard BioTools Inc View profile 539 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 https://www.standardbio.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

Europe microfluidics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.


Microfluidic components was the largest segment with a revenue share of 87.28% in 2025. Horizon Databook has segmented the Europe microfluidics market based on microfluidic components, microfluidic-based devices covering the revenue growth of each sub-segment from 2021 to 2033.


Europe accounted for the second-largest revenue share in 2021. The country has a high demand for diagnostics with growing funding to encourage academic research. For instance, in March 2020, Eden Tech initiated the IPANEMA project, which was financed by the EU Horizon 2020 research and innovation program.

The goal of the project was to incorporate paper-based nucleic acid testing methods into microfluidics devices for enhanced biosensing applications, such as the detection of toxigenic freshwater cyanobacteria agrifood pathogen detection and tissue engineering.

In addition, in 2021, the company launched the RENOIR European project: Muscle-on-a-chip for aging, to study how inflammatory response and other factors can hamper the restoration of damaged muscle tissues, and to build a muscle-on-a-chip platform as a prototype for pharmacological assays.

Reasons to subscribe to Europe microfluidics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe microfluidics market databook

  • Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe microfluidics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe microfluidics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe microfluidics market size, by country, 2021-2033 (US$M)

Europe Microfluidics Market Outlook Share, 2025 & 2033 (US$M)

Europe microfluidics market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online